Kemtile focuses on pharma flooring with Lab Innovations debut
For the first time ever, Kemtile will be exhibiting at the Lab Innovations exhibition, which takes place at the NEC, in Birmingham, on 30th and 31st October.
As the UK's largest annual trade exhibition dedicated to the entire laboratory industry, Lab Innovations will provide the perfect platform for Kemtile to showcase its hygienic flooring capabilities and credentials to over 3,000 laboratory decision makers on stand D12.
For four decades, the company has been the go-to hygienic flooring and drainage designer and installer for many of the UK's leading food and beverage brands.
Now part of the Stonhard group, which is well renowned internationally within the pharmaceutical sector, with clients such as such Astrazenca, Pfizer Biotechnology Ireland, Fusion Pharma, Rosemount Pharmaceutical, Aesica and GE Whatman, Kemtile is increasingly working with pharmaceutical manufacturing plants on complete floor systems.
It provides a one-stop shop for site surveys, specification, design, groundworks, drainage, site supervision, health and safety compliance and installation by its skilled in-house teams.
Using Stonhard products, Kemtile designs and installs sterile, easy to clean epoxy resin flooring and wall coverings to meet the unique requirements of pharmaceutical processing and manufacturing environments.
Kemtile's Richard Kay said: "Our joint capabilities and longstanding experience and reputation is already firmly positioning Kemtile, a Stonhard company, as one of the market leaders in hygienic flooring and drainage within the UK pharma sector.
"It's an important market for us and our presence, for the first time, at the show will provide us with an excellent opportunity to showcase our capabilities and experience."
25th October 2019
For all Kemtile journalist, press and media enquiries, requests for interviews, and print-quality artwork, please contact: Sue Souter, Souter PR, 01625 839319, email@example.com